Onkologie 2020: 14(Suppl.D): 75-77 | DOI: 10.36290/xon.2020.043

Radiotherapy in post-operative chylous ascites treatment

Lucie Hnidáková, Eva Kocmanová, Vladimír Rak
Klinika radiační onkologie LF MU, Masarykův onkologický ústav, Brno

Chylous ascites - accumulation of chylous liquid rich in triglycerides in abdominal cavity due to trauma or obstruction of lymfatic vessels - is a rather rare finding. The most common cause in adults is malignancy (hepatocellular carcinoma, dissemination of primary tumor - breast, colon, pancreas, ovaries, testes, kidneys, also small bowel lymphoma and retroperitoneal lymphoma), liver cirhossis or traumatic injury after operations in retroperitoneal space. Treatment is highly individual based on nutritional support and treatment of primary cause. If conservative managment fails, special techniques may be used - somatostatin injections, surgical therapy, embolization of lymphatic vessels, radiotherapy. Our patient developed chylous ascites after radical oncogynecological procedure.

Keywords: case report, chylous ascites, oncogynecology, lymphadenectomy, radiotherapy.

Published: June 2, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hnidáková L, Kocmanová E, Rak V. Radiotherapy in post-operative chylous ascites treatment. Onkologie. 2020;14(Suppl.D / Onkologické kazuistiky 3):75-77. doi: 10.36290/xon.2020.043.
Download citation

References

  1. Schneiderka P, et al. Kapitoly z klinické biochemie. Praha: Karolinum 2011: 365 s.
  2. Čihák R, et al. Anatomie 3. Praha: Grada, 2016: 832 s.
  3. Wolf D. Chylous ascites. Medscape [online]. 2019 September [cit. 3.1.2020]. Dostupné z https://emedicine.medscape.com/article/185777-overview.
  4. Corradini S, Liebig S, Niemoeller OM, et al. Successful radiation treatment of chylous ascites following pancreaticoduodenectomy. Strahlenther Onkol: Organ der Deutschen Rontgengesellschaft ... [et al]. 2015 May; 191(5): 448-452. Go to original source... Go to PubMed...
  5. Abana CO, Hammad H, Brown S, et al. Low-Dose Radiation Therapy is an Effective Treatment for Refractory Postoperative Chylous Ascites: A Case Report. Pract Radiat Oncol. 2019 May; 9(3): 153-157. Go to original source... Go to PubMed...
  6. Kim SW, Kim JH. Low-dose radiation therapy for massive chylous leakage after subtotal gastrectomy. Radiat Oncol J. 2017; 35(4): 380-384. doi:10.3857/roj.2017.00178 Go to original source... Go to PubMed...
  7. Sziklavari Z, Allgäuer M, Hübner G, et al. Radiotherapy in the treatment of postoperative chylothorax. J Cardiothorac Surg. 2013; 8: 72. Published 2013 Apr 8. doi:10.1186/1749-8090-8-72 Go to original source... Go to PubMed...
  8. Chatila R, Ferayorni L, Gupta T, et al. Local arterial vasoconstriction induced by octreotide in patients with cirrhosis. Hepatology 2000; 31: 572-576. Go to original source... Go to PubMed...
  9. Matsumoto T, Yamagami T, Kato T, et al. The effectiveness of lymphangiography as a treatment method for various chyle leakages. Br J Radiol. 2009; 82(976): 286-290. [Medline]. Go to original source... Go to PubMed...
  10. Nadolski GJ, Chauhan NR, Itkin M. Lymphangiography and lymphatic embolization for the treatment of refractory chylous ascites. Cardiovasc Intervent Radiol. 2018; 41(3): 415-423. [Medline]. Go to original source... Go to PubMed...
  11. Srinivasa RN, Gemmete JJ, Osher ML, et al. Endolymphatic Balloon-Occluded Retrograde Abdominal Lymphangiography (BORAL) and Embolization (BORALE) for the diagnosis and treatment of chylous ascites: approach, technical success, and clinical outcomes. Ann Vasc Surg. 201; 49: 49-56. [Medline].




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.